In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the announcement that Bristol Myers Squibb is purchasing RayzeBio, the use of artificial intelligence in discovering antibiotics that stop MRSA infections, and recent reports revealing an increase in medical errors at hospitals owned by private equity firms.

Podcast Tags: healthcare, healthcare news, life sciences, mergers & acquisitions, radiopharma, medtech, artificial intelligence, antibiotics, health services, providers, private equity, hospitals 

Source Links: 

• BMS enters radiopharma race with $4.1B acquisition of RayzeBio just 3 months after biotech went public 
• ‘Explainable’ AI discovers new class of antibiotics that stop MRSA in mice 
• Discovery of a structural class of antibiotics with explainable deep learning 
• Serious Medical Errors Rose After Private Equity Firms Bought Hospitals  

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.